updated 1/23/2007 9:18:30 AM ET 2007-01-23T14:18:30

Health care giant Johnson & Johnson on Tuesday posted a 3.5 percent increase in fourth-quarter profit as higher sales, especially for consumer products overseas, were offset by costs of a major acquisition.

The New Brunswick, N.J.-based maker of contraceptives, contact lenses, prescription drugs and baby products reported net income of $2.17 billion, or 74 cents per share, up from $2.10 billion, or 70 cents per share, in 2005’s final quarter.

Excluding an after-tax charge of $217 million for the acquisition of Pfizer Consumer Healthcare late in the fourth quarter, income would have been $2.4 billion, or 81 cents per share, the company said.

Revenues totaled $13.68 billion, up 8.5 percent from $12.61 billion in the last quarter of 2005.

Analysts surveyed by Thomson First Call were expecting earnings of 79 cents per share and sales of $13.68 billion.

“Johnson & Johnson had a solid year in 2006, delivering double-digit growth in earnings per share while continuing to invest in building our businesses for the future,” William C. Weldon, chairman and chief executive officer, said in a statement.

“We’re very excited about the completion of the Pfizer Consumer Healthcare acquisition, which not only brings to Johnson & Johnson some of the world’s premier consumer brands, but also builds upon our broad base in human health care.”

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com